In this article, we discuss the 5 dividend stocks in Robert Pohly’s portfolio. If you want to read our detailed analysis of Samlyn Capital’s past performance and investment strategies, go directly to read Robert Pohly’s Samlyn Capital Portfolio: 10 Dividend Stock Picks.
5. Williams-Sonoma, Inc. (NYSE:WSM)
Number of Hedge Fund Holders: 40
Samlyn Capital’s Stake Value: $49,289,000
Dividend Yield as of March 1: 1.96%
Williams-Sonoma, Inc. (NYSE:WSM), an American consumer retail company, experienced a positive hedge fund sentiment in Q4 2021, as 40 hedge funds tracked by Insider Monkey held positions in the company, up from 31 in the previous quarter. These stakes hold a consolidated value of $646.7 million. Select Equity Group was the company’s largest shareholder in Q4, with stakes valued at $292.8 million.
In December 2021, Williams-Sonoma, Inc. (NYSE:WSM) announced a quarterly dividend of $0.71, increasing it by 20.3% from its previous dividend. As of March 1, the stock’s dividend yield stood at 1.96%. Williams-Sonoma, Inc. (NYSE:WSM) has been increasing its dividends for the past 12 years. Moreover, the company’s dividend has tripled in the past 10 years. This January, RBC Capital upgraded Williams-Sonoma, Inc. (NYSE:WSM) to Outperform, with a $202 price target.
Williams-Sonoma, Inc. (NYSE:WSM) is one of the latest acquisitions of Samlyn Capital in Q4. The hedge fund started building its position in the company with shares worth roughly $50 million, which accounted for 0.67% of Robert Pohly’s portfolio.
Vltava Fund mentioned Williams-Sonoma, Inc. (NYSE:WSM) in its Q4 2021 investor letter. Here is what the firm has to say:
“There were two new additions to the portfolio last year – (including) shares of the retail company Williams-Sonoma. I mentioned both purchases already in the previous newsletter to shareholders. At first sight, these were only minor changes. There were many more transactions in the portfolio over the past year, however. Most purchases were directed to shares we have already held in the portfolio. We have been purchasing virtually all the stocks we hold, many of them repeatedly. While we are by no means opposed to anything new and always are looking for new investment opportunities, we generally tend to gravitate to what we already have in the portfolio, to what we know well, and moreover what we see is working out well.”
4. Huntsman Corporation (NYSE:HUN)
Number of Hedge Fund Holders: 32
Samlyn Capital’s Stake Value: $27,503,000
Dividend Yield as of March 1: 2.10%
Wall Street analysts provided a positive outlook on Huntsman Corporation (NYSE:HUN), amidst inflation fears. In February, both Wells Fargo and KeyBanc raised their price targets on the American chemical company to $50 and $48, respectively.
By the end of Q4 2021, 32 hedge funds tracked by Insider Monkey were bullish on the company, holding stakes worth over $1.1 billion. In comparison, 26 hedge funds held stakes in the company in the preceding quarter, valued at roughly $985 million.
Huntsman Corporation (NYSE:HUN) has been paying dividends to shareholders since 2007. On February 14, the company announced a 13.3% increase in its quarterly dividend at $0.2125 per share, with a dividend yield of 2.10%, as of March 1. Samlyn Capital started building its position in Huntsman Corporation (NYSE:HUN) during the fourth quarter of 2021, with shares worth over $27.5 million. The company accounted for 0.37% of Robert Pohly’s portfolio.
3. MetLife, Inc. (NYSE:MET)
Number of Hedge Fund Holders: 36
Samlyn Capital’s Stake Value: $33,370,000
Dividend Yield as of March 1: 2.84%
MetLife, Inc. (NYSE:MET) is a New York-based insurance company that also provides employee benefits programs. In 2021, the company hiked its quarterly dividend by 4.3% at $0.48 per share. The stock’s dividend yield stood at 2.84%, as recorded on March 1. MetLife, Inc. (NYSE:MET) has been paying dividends for the past 20 years while maintaining a 9-year streak of dividend growth.
This January, Jefferies appreciated the company’s stable growth and high returns and initiated its coverage on MetLife, Inc. (NYSE:MET) with a Buy rating and a $74 price target. In Q4 2021, Samlyn Capital held a stake worth over $33.3 million in the company, which represented 0.46% of the hedge fund’s 13F portfolio.
By the end of Q4 2021, 36 hedge funds tracked by Insider Monkey held stakes in MetLife, Inc. (NYSE:MET), down from 39 in the previous quarter. The consolidated value of these stakes is over $1 billion. Among these hedge funds, Pzena Investment Management held the largest stake in the company in Q4, valued at $330.7 million.
2. American Eagle Outfitters, Inc. (NYSE:AEO)
Number of Hedge Fund Holders: 31
Samlyn Capital’s Stake Value: $45,686,000
Dividend Yield as of March 1: 3.42%
In Q4 2021, Samlyn Capital increased its stake by 35% in American Eagle Outfitters, Inc. (NYSE:AEO), an American lifestyle and clothing company. The hedge fund held a stake worth roughly $45.7 million in the company, which represented 0.63% of Robert Pohly’s portfolio.
This January, Barclays set a $38 price target on American Eagle Outfitters, Inc. (NYSE:AEO), with an Overweight rating on the shares. In 2021, the company increased its quarterly dividend by 31% at $0.18 per share. The stock’s dividend yield, as of March 1, stood at 3.42%.
As per Insider Monkey’s Q4 data, the number of hedge funds holding positions in American Eagle Outfitters, Inc. (NYSE:AEO) grew to 31, from 24 in the previous quarter. The total value of these stakes is roughly $1.2 billion.
1. Viatris Inc. (NASDAQ:VTRS)
Number of Hedge Fund Holders: 58
Samlyn Capital’s Stake Value: $34,865,000
Dividend Yield as of March 1: 4.36%
An American healthcare company, Viatris Inc. (NASDAQ:VTRS) initiated paying dividends to shareholders in the first quarter of 2021. On January 6, the company announced a 9% increase in its quarterly dividend at $0.12 per share. The stock’s dividend yield stood at 4.36, as recorded on March 1.
Viatris Inc. (NASDAQ:VTRS) is one of the recent holdings of Samlyn Capital, holding shares worth roughly $34.9 million. The company represented 0.48% of Robert Pohly’s portfolio. Recently, BMO Capital set a $19 price target on Viatris Inc. (NASDAQ:VTRS), with an Outperform rating on the shares, appreciating the company’s valuation.
By the end of Q4 2021, 58 hedge funds tracked by Insider Monkey reported owning stakes in Viatris Inc. (NASDAQ:VTRS), up from 55 in the previous quarter. The total value of these stakes is over $1.44 billion. Laurion Capital Management held the largest stake in the company in Q4, worth $464 million.
Davis Fund mentioned Viatris Inc. (NASDAQ:VTRS) in its Q3 2021 investor letter. Here is what the firm has to say:
“Also within healthcare, we own Viatris, the newly conceived union of Mylan, a generics/specialty pharma company, and Pfizer’s Upjohn business, which includes a portfolio of 20 largely off-patent branded Pfizer drugs including Lipitor, Lyrica, Norvasc and Viagra. The combined business is the largest generics/off-patent drug manufacturer in the world and is highly diversified by geography, with 70% of revenue outside the U.S.”
You can also take a look at 10 Best Value Stocks To Buy Now and 10 Best Climate Change Stocks to Buy Now
